J
Jaime Prat
Researcher at Autonomous University of Barcelona
Publications - 221
Citations - 17353
Jaime Prat is an academic researcher from Autonomous University of Barcelona. The author has contributed to research in topics: Carcinoma & Serous fluid. The author has an hindex of 67, co-authored 218 publications receiving 15497 citations. Previous affiliations of Jaime Prat include Harvard University.
Papers
More filters
Journal ArticleDOI
Promoter Hypermethylation and BRCA1 Inactivation in Sporadic Breast and Ovarian Tumors
Manel Esteller,Jose Maria Silva,Gemma Domínguez,Félix Bonilla,Xavier Matias-Guiu,Enrique Lerma,Elena Bussaglia,Jaime Prat,I. Clara Harkes,Elizabeth A. Repasky,Edward Gabrielson,Mieke Schutte,Stephen B. Baylin,James G. Herman +13 more
TL;DR: In this article, the role of hypermethylation of the BRCA1 gene's promoter region was analyzed in the presence of heterozygosity (LOH) and loss of one copy of the gene in tumors.
Journal ArticleDOI
Staging classification for cancer of the ovary, fallopian tube, and peritoneum
TL;DR: The FIGO Committee on Gynecologic Oncology feels that it is time to revise this classification to improve utility and reproducibility.
Journal ArticleDOI
Uterine sarcomas: A review
Emanuela D'Angelo,Jaime Prat +1 more
TL;DR: This review summarizes the available clinicopathological data on uterine sarcomas classified by the WHO diagnostic criteria and concludes that immunohistochemical studies of oncoproteins as well as molecular analysis of non-random translocations will lead to an accurate and prognostically relevant classification of these rare tumors.
Journal ArticleDOI
Revised FIGO staging for carcinoma of the cervix uteri
Neerja Bhatla,Jonathan S. Berek,Mauricio Cuello Fredes,Lynette Denny,Seija Grénman,Kanishka Karunaratne,Sean Kehoe,Ikuo Konishi,Alexander B. Olawaiye,Jaime Prat,Rengaswamy Sankaranarayanan,Rengaswamy Sankaranarayanan,James Brierley,David G. Mutch,Denis Querleu,David Cibula,Michael A. Quinn,Hennie Botha,Lax Sigurd,Laurel W. Rice,Hee-Sug Ryu,Hextan Y.S. Ngan,Johanna Mäenpää,Andri Andrijono,Gatot Purwoto,Amita Maheshwari,Uttam D. Bafna,Marie Plante,Jayashree Natarajan +28 more
TL;DR: To revise FIGO staging of carcinoma of the cervix uteri, allowing incorporation of imaging and/or pathological findings, and clinical assessment of tumor size and disease extent.
Journal ArticleDOI
Ovarian carcinomas: five distinct diseases with different origins, genetic alterations, and clinicopathological features.
TL;DR: Recent advances in the molecular pathology which have greatly improved the understanding of the biology of ovarian carcinoma are summarized and are also relevant to patient management.